page_banner

Products

Guanosine Cas:118-00-3 White to off-white crystalline powder

Short Description:

Catalog Number: XD90577
Cas: 118-00-3
Molecular Formula: C10H13N5O5
Molecular Weight: 283.24
Availability: In Stock
Price:  
Prepack: 100g USD10
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD90757
Product Name Guanosine

CAS

118-00-3

Molecular Formula

C10H13N5O5

Molecular Weight

283.24
Storage Details Ambient
Harmonized Tariff Code 29349990

 

Product Specification

Appearance White to off-white crystalline powder
Assay 99% min
Heavy metals <10ppm
AS <1ppm
Residue on Ignition <0.1%

 

Several guanosine analogues, i.e. acyclovir (and its oral prodrug valaciclovir), penciclovir (in its oral prodrug form, famciclovir) and ganciclovir, are widely used for the treatment of herpesvirus [i.e. herpes simplex virus type 1 (HSV-1), and type 2 (HSV-2), varicella-zoster virus (VZV) and/or human cytomegalovirus (HCMV)] infections. In recent years, several new guanosine analogues have been developed, including the 3-membered cyclopropylmethyl and -methenyl derivatives (A-5021 and synguanol) and the 6-membered D- and L-cyclohexenyl derivatives. The activity of the acyclic/carbocyclic guanosine analogues has been determined against a wide spectrum of viruses, including the HSV-1, HSV-2, VZV, HCMV, and also human herpesviruses type 6 (HHV-6), type 7 (HHV-7) and type 8 (HHV-8), and hepatitis B virus (HBV). The new guanosine analogues (i.e. A-5021 and D- and L-cyclohexenyl G) were found to be particularly active against those viruses (HSV-1, HSV-2, VZV) that encode for a specific thymidine kinase (TK), suggesting that their antiviral activity (at least partially) depends on phosphorylation by the virus-induced TK. Marked antiviral activity was also noted with A-5021 against HHV-6 and with D- and L-cyclohexenyl G against HCMV and HBV. The antiviral activity of the acyclic/carbocyclic nucleoside analogues could be markedly potentiated by mycophenolic acid, a potent inhibitor of inosine 5'-monophosphate (IMP) dehydrogenase. The new carbocyclic guanosine analogues (i.e. A-5021 and D- and L-cyclohexenyl G) hold great promise, not only as antiviral agents for the treatment of herpesvirus infections, but also an antitumor agents for the combined gene therapy/chemotherapy of cancer, provided that (part of) the tumor cells have been transduced by the viral (HSV-1, VZV) TK gene.


  • Previous:
  • Next:

  • Close

    Guanosine Cas:118-00-3 White to off-white crystalline powder